Pages that link to "Q74604747"
Jump to navigation
Jump to search
The following pages link to Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer (Q74604747):
Displaying 50 items.
- The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract (Q27687612) (← links)
- Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy. (Q28303251) (← links)
- Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience (Q28365788) (← links)
- Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy (Q30459126) (← links)
- High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive (Q33360403) (← links)
- A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis (Q33656736) (← links)
- Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma (Q33657791) (← links)
- Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer (Q33728359) (← links)
- Chemotherapy as a component of multimodal therapy for gastric carcinoma (Q33867249) (← links)
- Multidisciplinary approach to esophageal and gastric cancer (Q33932046) (← links)
- Modern staging in gastric cancer (Q34348327) (← links)
- Recent advances in the treatment of gastric cancer (Q34385364) (← links)
- Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials? (Q35031712) (← links)
- Curative treatment of gastric cancer: towards a multidisciplinary approach? (Q35097713) (← links)
- Chemotherapy in gastric cancer: a review and updated meta-analysis (Q35108798) (← links)
- Chemoradiation for resectable gastric cancer (Q35193685) (← links)
- Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer (Q36218208) (← links)
- Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China (Q36307739) (← links)
- Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer (Q36532854) (← links)
- Adjuvant and preoperative therapy for localized gastric cancer. (Q37076527) (← links)
- The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer (Q37076617) (← links)
- The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies (Q37121679) (← links)
- A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer (Q37174037) (← links)
- Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer (Q37204825) (← links)
- Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer. (Q37236380) (← links)
- Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies (Q37241496) (← links)
- Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma (Q37429923) (← links)
- FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer (Q37434552) (← links)
- Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol (Q37497874) (← links)
- A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer p (Q37580616) (← links)
- Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas (Q37681788) (← links)
- A novel grade-lymph node ratio model predicts the prognosis of the advanced gastric cancer patients after neoadjuvant radiotherapy (Q37706749) (← links)
- Perioperative chemotherapy for gastroesophageal cancer in British Columbia: a multicentre experience (Q37719600) (← links)
- Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction (Q37777087) (← links)
- Gastric cancer: surgery in 2011 (Q37828465) (← links)
- Gastric Adenocarcinoma Surgery and Adjuvant Therapy (Q37925938) (← links)
- Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer (Q38192620) (← links)
- What make differences in the outcome of adjuvant treatments for resected gastric cancer? (Q38247980) (← links)
- Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer? (Q38264664) (← links)
- Current status of management of malignant disease: current management of gastric cancer (Q38319561) (← links)
- Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy (Q38712738) (← links)
- Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma? (Q38868199) (← links)
- Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan (Q39155658) (← links)
- Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer (Q39213501) (← links)
- Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor (Q39497734) (← links)
- Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer (Q39727817) (← links)
- Gastric Adenocarcinoma. (Q40526084) (← links)
- Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy (Q41859828) (← links)
- Organotypic slice cultures of human gastric and esophagogastric junction cancer (Q42420690) (← links)
- Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report (Q42422268) (← links)